Yu Waye Chu

Technik-/Wissenschafts-/F&E-Leiter bei CYTOMX THERAPEUTICS, INC.

Vermögen: 586 416 $ am 30.04.2024

56 Jahre

Health Technology

Consumer Services

Aktive Positionen von Yu Waye Chu

Unternehmen	Position	Beginn	Ende
CYTOMX THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	17.07.2023	-

Unternehmen	Position	Beginn	Ende
FATE THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	18.04.2019	14.07.2023
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01.01.2009	01.04.2019

Princeton University	Undergraduate Degree
University of Rochester School of Medicine & Dentistry	Doctorate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
FATE THERAPEUTICS, INC.	Health Technology
CYTOMX THERAPEUTICS, INC.	Health Technology

Private Unternehmen	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology

Private Unternehmen

Health Technology